

Relmada Therapeutics is a clinical stage pain management company developing products for the treatment of chronic pain.
| Headquarter | P.O. Box 1266 Blue Bell, PA United States of America |
|---|---|
| Website | www.relmada.com |
| Founding Date | 2007 |
| Tel | 610-272-2071 |
| Company Status | Private |
Relmada Therapeutics competitors include Biogen, MyoKardia, and Reata Pharmaceuticals. Relmada Therapeutics ranks 4th in Overall Culture Score on Comparably vs its competitors. See below how Relmada Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
1 employee at Relmada Therapeutics has reviewed Relmada Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users in Camden, NJ about their company is that it was very prepared on their first day. Camden, NJ employees concluded that their overall onboarding experience was positive. 75% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Relmada Therapeutics employees have provided insight into whether or not they clearly understand Relmada Therapeutics' KPIs and OKRs.

Sergio Traversa CEO / President
Sergio Traversa serves as the CEO / President of Relmada Therapeutics.

Douglas Beck Chief Financial Officer
Douglas Beck serves as the Chief Financial Officer of Relmada Therapeutics.

No Recent Jobs found for Relmada Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

What is Relmada Therapeutics address?
Relmada Therapeutics location is at P.O. Box 1266
Who is the CEO of Relmada Therapeutics?
Relmada Therapeutics CEO is Sergio Traversa, their score by employees is 10
What is Relmada Therapeutics eNPS?
The eNPS for Relmada Therapeutics is -100
Who are Relmada Therapeutics competitors?
Relmada Therapeutics main competitors are Biogen, MyoKardia, Reata Pharmaceuticals
Who is Relmada Therapeutics leadership?
Douglas Beck are part of Relmada Therapeutics leadership, Sergio Traversa is the CEO